Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/1998
12/08/1998US5846528 Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence
12/08/1998US5846527 Continuous cell line and vaccine against avian coccidia
12/08/1998US5846489 System for opening closures of vessels and for the contamination-free operation of reaction sequences
12/08/1998US5846225 Gene transfer therapy delivery device and method
12/08/1998CA2066612C Method of producing fusion proteins
12/08/1998CA2056086C Cloned gene encoding for bacteriocin from pediococcus acidilactici
12/08/1998CA2055598C Feline calicivirus gene
12/08/1998CA1340174C Activation of nf-kb precursor
12/08/1998CA1340173C Production and purification of a protein fused to a binding protein
12/08/1998CA1340172C Diagnostics and vaccines for mycobacteria in public health, medical, andveterinary practise
12/08/1998CA1340160C Method and reagents for detecting nucleic acid sequences
12/06/1998CA2234413A1 Novel compounds
12/05/1998CA2233591A1 Novel compounds
12/04/1998CA2233590A1 Novel compounds
12/04/1998CA2233587A1 Novel compounds
12/04/1998CA2205081A1 A method to map and isolate regions of chromosomes that interact or associate functionally within or between chromosomes in vivo
12/03/1998WO1998054572A1 Methods for evaluating tissue morphogenesis and activity
12/03/1998WO1998054547A1 Magnetic rotation sensor
12/03/1998WO1998054366A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
12/03/1998WO1998054365A1 Control of immune responses by modulating activity of glycosyltransferases
12/03/1998WO1998054362A1 Length determination of nucleic acid repeat sequences by discontinuous primer extension
12/03/1998WO1998054361A1 GENE DIAGNOSIS OF DISEASES WHEREIN TNF-$(g)a PROMOTERS PARTICIPATE
12/03/1998WO1998054360A1 Methods for analyzing animal products
12/03/1998WO1998054359A1 Prediction of inflammatory disease associated with il-1 geneloci polymorphisms
12/03/1998WO1998054353A1 Methods of making an rnp particle having nucleotide integrase activity
12/03/1998WO1998054348A1 Telomere-associated chromosome fragmentation
12/03/1998WO1998054347A1 Integrin-targeting vectors having transfection activity
12/03/1998WO1998054346A1 Alternatively targeted adenovirus
12/03/1998WO1998054345A1 Mini-adenoviral vector
12/03/1998WO1998054344A2 Modulators of morphogen expression and methods of identifying the same
12/03/1998WO1998054342A1 Methods for coexpression of more than one gene using at least one internal ribosome entry site (ires)
12/03/1998WO1998054340A1 Method for enhancement of naturally occurring cytoplasmic male sterility and for restoration of male fertility and uses thereof in hybrid crop production
12/03/1998WO1998054339A1 PROCESS FOR PREPARING RECOMBINANT PROTEINS USING HIGHLY EFFICIENT EXPRESSION VECTOR FROM $i(SACCHAROMYCES CEREVISIAE)
12/03/1998WO1998054338A1 Method for promoter identification
12/03/1998WO1998054336A1 Method for mass production of antimicrobial peptide
12/03/1998WO1998054335A1 In vivo modification of galactomannans in guar by expression of udp-galactose epimerase antisense rna
12/03/1998WO1998054334A1 Cloning of udp-galactose epimerase
12/03/1998WO1998054333A2 Mammalian caax processing enzymes
12/03/1998WO1998054332A1 Cellulase preparation containing highly active cellulase sce3
12/03/1998WO1998054331A2 High level expression of glycosyltransferases
12/03/1998WO1998054330A1 Methods of in situ modification of plant genes
12/03/1998WO1998054328A2 Genes controlling floral development and apical dominance in plants
12/03/1998WO1998054327A1 Proteins having insecticidal activities and method of use
12/03/1998WO1998054326A1 Human chemokine zchemo-8
12/03/1998WO1998054325A1 Human frp and fragments thereof including methods for using them
12/03/1998WO1998054324A1 Human multiple endocrine neoplasia type 1 protein
12/03/1998WO1998054323A1 The siva genes involved in cd27-mediated apoptosis
12/03/1998WO1998054322A1 Osf2/cbfa1 compositions and methods of use
12/03/1998WO1998054321A1 New human dp1 homolog
12/03/1998WO1998054320A1 Human metaxin protein
12/03/1998WO1998054319A1 Metal response element binding protein
12/03/1998WO1998054318A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
12/03/1998WO1998054317A1 Human immunodeficiency virus co-receptor variants associated with resistance to virus infection
12/03/1998WO1998054316A1 Sodium channel receptor
12/03/1998WO1998054315A1 Cell growth-controlling oligonucleotides
12/03/1998WO1998054313A2 Dna methyltransferase genomic sequences and antisense oligonucleotides
12/03/1998WO1998054312A1 Ribosome complexes as selection particles for in vitro display and evolution of proteins
12/03/1998WO1998054311A1 Zinc finger protein derivatives and methods therefor
12/03/1998WO1998054310A2 Methods for activating inactive genes and methods for altering the rate of development of cells, tissues and organisms
12/03/1998WO1998054309A1 GENETIC DIAGNOSIS FOR DISEASES WHEREIN TNF-α PROMOTER PARTICIPATES
12/03/1998WO1998054308A2 Polyketides and their synthesis and use
12/03/1998WO1998054307A1 Knockout mice and their progeny with disrupted serine protease genes
12/03/1998WO1998054306A1 Method for isolating an intracellular substance
12/03/1998WO1998054303A1 Mammalian lysophosphatidic acid acyltransferase
12/03/1998WO1998054300A1 Nematode model for alzheimer's disease
12/03/1998WO1998054298A1 Overexpression of cardiac receptors for myocardial protection
12/03/1998WO1998054225A2 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes
12/03/1998WO1998054223A2 Immunological method
12/03/1998WO1998054220A1 PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR
12/03/1998WO1998054217A1 Angiostatin fragments and method of use
12/03/1998WO1998054216A1 Gene and amino acid sequences for novel transcription factor
12/03/1998WO1998054214A2 Hypersensitive response elicitor fragments and uses thereof
12/03/1998WO1998054213A2 Neurotrophic factor receptors
12/03/1998WO1998054212A2 Human type 3 ryanodine receptor protein and dna molecules coding therefor
12/03/1998WO1998054206A1 32 human secreted proteins
12/03/1998WO1998054203A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies
12/03/1998WO1998054202A1 Human tumor necrosis factor receptor tr10
12/03/1998WO1998054199A1 Tissue plasminogen activator-like protease
12/03/1998WO1998054130A1 Compounds, preparation and use for transferring nucleic acids into cells
12/03/1998WO1998053912A1 Device for selectively filtering under reduced pressure and for vacuum drying sample liquids or drops of sample liquids as well as use of said device
12/03/1998WO1998053856A1 Methods for the detection, treatment, and prevention of neurodegeneration
12/03/1998WO1998053854A1 Antigen delivery system
12/03/1998WO1998053853A1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy
12/03/1998WO1998053846A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
12/03/1998WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA
12/03/1998WO1998053838A2 A soluble laminin receptor precursor and methods to inhibit its interactions
12/03/1998WO1998053804A1 Methods and compositions for targeting compounds to muscle
12/03/1998WO1998053801A1 Conjugated peptide nucleic acids having enhanced cellular uptake
12/03/1998WO1998045712A3 20 human secreted proteins
12/03/1998WO1998045332A3 Humanized antibodies and methods for forming humanized antibodies
12/03/1998WO1998045331A3 Anti-vegf antibodies
12/03/1998WO1998044123A3 O-linked glcnac transferase (ogt): cloning, molecular expression, and methods of use
12/03/1998WO1998042827A3 Gene encoding oxalate decarboxylase from aspergillus phoenicis
12/03/1998WO1998042739A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998041636A3 Replication genes and gene products from small cryptic plasmids and methods for constructing high-copy number plasmid vectors
12/03/1998WO1998041631A3 β-CATENIN, TCF-4, AND APC INTERACT TO PREVENT CANCER
12/03/1998WO1998040491A3 Pesticidal bacillus thuringiensis strains
12/03/1998WO1998040486A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998040478A3 Antisense inhibition of human stat-6
12/03/1998WO1998040470A3 Cytochrome p450 monooxygenases
1 ... 3460 3461 3462 3463 3464 3465 3466 3467 3468 3469 3470 3471 3472 3473 3474 3475 3476 3477 3478 3479 3480 ... 4023